A股異動 | 藍英裝備(300293.SZ)跌逾8% 控股股東及其一致行動人擬減持不超6%股份
格隆匯10月13日丨藍英裝備(300293.SZ)現報23.6元,跌8.14%,暫成交4.3億元,最新總市值63億元。藍英裝備昨晚公佈,控股股東瀋陽藍英自動控制有限公司及其一致行動人中巨國際有限公司計劃在自公告發布之日起15個交易日之後的6個月內以集中競價和大宗交易方式減持公司股份不超過1620萬股(不超過公司總股本的6%)。此外據悉,藍英裝備曾公佈中期業績稱,期內歸屬於上市公司股東的淨虧損2156.92萬元,上年同期盈利1277.91萬元;基本每股虧損0.0799元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.